LICN revenueFY2025$24.52M
- FY YoY
- -40.9%
- 5Y CAGR
- -4.4%
LICN revenue was $24.52M for fiscal 2025 (ended Dec 31, 2025), down 40.9% from fiscal 2024. Compound annual growth was -4.4% over 5 years. It rose in 3 of the last 5 fiscal years.
Lichen International Limited (LICN) financials
For fiscal 2025 (ended Dec 31, 2025), Lichen International Limited reported $24.52M of revenue and -$21.96M of net income.
- Revenue, FY2025
- $24.52M
- Revenue growth, YoY
- -40.9%
- Net income, FY2025
- -$21.96M
- Net margin
- -89.6%
- Free cash flow, FY2025
- -$17.85M
- EPS, diluted, FY2025
- -$4.11
- Cash
- $26.91M
- P/S
- 0.21
- Market cap
- $5.1M
FY2020FY2025
FY2020FY2025
FY2021FY2025
LICN revenue and earnings growth
LICN net incomeFY2025-$21.96M
LICN net income was -$21.96M for fiscal 2025 (ended Dec 31, 2025), compared with -$6.14M in fiscal 2024.
LICN EPSFY2025-$4.11
LICN diluted EPS was -$4.11 for fiscal 2025 (ended Dec 31, 2025).
LICN free cash flowFY2025-$17.85M
LICN free cash flow was -$17.85M for fiscal 2025 (ended Dec 31, 2025), compared with -$5.61M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | $24.52M | $41.48M | $39.76M | $33.80M | $34.30M | $30.67M |
| Cost of revenue | $15.38M | $15.80M | $15.44M | $13.61M | $13.82M | $11.83M |
| Gross profit | $9.14M | $25.67M | $24.32M | $20.19M | $20.48M | $18.84M |
| Selling, general and admin | $12.91M | $17.70M | $8.94M | $7.43M | $7.17M | $8.46M |
| Operating income | -$18.07M | -$4.55M | $12.26M | $10.65M | $11.30M | $8.79M |
| Pre-tax income | -$21.79M | -$4.17M | $11.59M | $10.74M | $11.51M | $9.00M |
| Income tax | $0 | $1.95M | $3.25M | $2.92M | $3.05M | $2.59M |
| Net income | -$21.96M | -$6.14M | $8.34M | $7.82M | $8.46M | $6.41M |
| EPS, basic | -$4.11 | -$34.79 | $63.96 | $69.50 | $76.00 | $56.00 |
| EPS, diluted | -$4.11 | -$34.79 | $63.96 | $69.50 | $76.00 | $56.00 |
| Diluted shares | 5.3M | 175,897 | 130,363 | 112,500 | 112,500 | 112,500 |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $26.91M | $26.71M | $25.86M | $22.60M | $16.84M | $8.66M |
| Receivables | - | - | $4.46M | $3.54M | $419.0K | - |
| Inventory | $0 | $67.0K | $87.0K | $127.0K | $150.0K | - |
| Current assets | $36.17M | $34.01M | $40.13M | $27.27M | $23.89M | - |
| Goodwill | $791.0K | $4.45M | $0 | - | - | - |
| Total assets | $75.57M | $79.84M | $65.55M | $46.52M | $42.94M | - |
| Current liabilities | $4.68M | $4.27M | $4.09M | $5.23M | $6.11M | - |
| Short-term debt | - | - | $1.59M | $1.06M | $345.0K | - |
| Total liabilities | $5.02M | $4.28M | $4.13M | $5.42M | $6.11M | - |
| Shareholders' equity | $70.55M | $73.18M | $61.42M | $41.11M | $36.83M | $27.64M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$17.85M | -$5.57M | $557.0K | $10.77M | $7.30M | $8.35M |
| Capital expenditures | $0 | $36.0K | $3.20M | $1.95M | $28.0K | - |
| Free cash flow | -$17.85M | -$5.61M | -$2.65M | $8.82M | $7.28M | - |
| Investing cash flow | -$5.48M | -$9.89M | -$9.87M | -$2.84M | $561.0K | -$1.16M |
| Financing cash flow | $23.61M | $13.09M | $14.10M | -$327.0K | - | -$4.35M |
| Stock-based compensation | $314.0K | $3.41M | $0 | - | - | - |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue growth, YoY | -40.9% | 4.3% | 17.6% | -1.4% | 11.8% | - |
| Net income growth, YoY | - | - | 6.7% | -7.6% | 32.1% | - |
| EPS growth, YoY | - | - | -8.0% | -8.6% | 35.7% | - |
| Gross margin | 37.3% | 61.9% | 61.2% | 59.7% | 59.7% | 61.4% |
| Operating margin | -73.7% | -11.0% | 30.8% | 31.5% | 32.9% | 28.7% |
| Net margin | -89.6% | -14.8% | 21.0% | 23.1% | 24.7% | 20.9% |
| Free cash flow margin | -72.8% | -13.5% | -6.7% | 26.1% | 21.2% | - |
| Return on equity | -31.1% | -8.4% | 13.6% | 19.0% | 23.0% | 23.2% |
| Return on assets | -29.1% | -7.7% | 12.7% | 16.8% | 19.7% | - |
| Current ratio | 7.73 | 7.96 | 9.81 | 5.21 | 3.91 | - |
Source: XBRL data Lichen International Limited files with the SEC, latest filing dated Apr 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-200, first reported Apr 29, 2025.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
LICN peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| LICN | $24.52M | -40.9% | -$21.96M | -89.6% | $5.1M |
| GIB | C$15.91B | +8.4% | C$1.66B | 10.4% | $19.15B |
| BAH | $10.98B | -6.2% | $784.00M | 7.1% | $10.28B |
| G | $5.34B | +6.7% | $588.48M | 11.0% | $7.12B |
| FCN | $3.98B | +7.8% | $233.42M | 5.9% | $5.29B |
| RHI | $5.30B | -2.9% | $121.73M | 2.3% | $4.33B |
| EXPO | $659.07M | +15.4% | $114.67M | 17.4% | $4.06B |
| HURN | $1.86B | +12.3% | $113.54M | 6.1% | $2.55B |
| MAN | $18.92B | +7.3% | $120.30M | 0.6% | $2.07B |
LICN FAQ
9 questionsWhat is LICN revenue?
Lichen International Limited (LICN) reported $24.52M of revenue for fiscal 2025 (ended Dec 31, 2025). That is down 40.9% from the year before.Is LICN profitable?
No. Lichen International Limited reported a net loss of $21.96M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does LICN have?
Lichen International Limited reported $26.91M in cash and cash equivalents on its most recent balance sheet in SEC filings.How fast is LICN revenue growing?
Lichen International Limited's revenue changed -40.9% in fiscal 2025, to $24.52M. Its compound annual growth rate was -4.4% over 5 years.What is LICN gross margin?
Lichen International Limited's gross profit was $9.14M on $24.52M of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of 37.3%.What is LICN free cash flow?
Lichen International Limited generated -$17.85M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -$17.85M less capital expenditures.What is LICN earnings per share?
Diluted earnings per share were -$4.11 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did LICN last report financial results?
The latest statements here come from Lichen International Limited's 20-F filed on Apr 28, 2026, covering the period ended Dec 31, 2025.Where does this LICN financial data come from?
Quantisnow builds these statements from the structured XBRL data Lichen International Limited files with the SEC. It is provided for information only and is not investment advice.